The full letter to the United States House of Representatives can be viewed here.
patents
ACI in the Huffington Post: Patent Trolls Cost Consumers
This piece was authored by Steve Pociask and is available at the Huffington Post.
ACI in the Daily Caller: Patent Reform and the American Dream
Written by ACI’s Zack Christenson, this Daily Caller op-ed discusses the need for patent reform. You can follow the link or this URL — http://dailycaller.com/2013/10/09/the-american-dream-depends-on-patent-reform/
For Whom the Patent Trolls
This week, representatives from a few startup tech companies made their way to Capitol Hill and the White House to show firsthand to lawmakers the detrimental effect that patent trolls can bring to small businesses and startups trying to make their way. Their goal—show how these patent trolls are, in President Obama’s words, “extorting” money […]
ACI in the Huffington Post
Steve Pociask wrote a piece on how one patent pool may be overcharging and leading to higher electronic prices. To see the blog, visit the Huffington Post website.
ACI Op-Ed in the Daily Caller: Patent Pool Consumer Ripoff
The Daily Caller ran an op-ed written by Steve Pociask on May 13, 2013. The piece discusses how one patent pool may be sticking it to consumers. The piece can be read by clicking here.
The Need to Fix Patent Abuses
Most people know patents as tools to protect inventors and creators. Our patent system provides an incentive to follow through on a good idea or a new way of doing something. It ensures that inventors will be able to benefit financially from their invention, disallowing others from taking a product and selling it on their […]
Professors Blackstone and Fuhr on the Benefits of Biosimilar Competition
Benefits from Biosimilar Competition Erwin A. Blackstone and Joseph P. Fuhr, Jr. (For a printable version of this ConsumerGram with its footnotes, please click here biosimilar2-1) The U.S. is now developing a process for expedited approval of biosimilars. Biopharmaceuticals are far more complex and costly to develop and produce than chemical drugs. Biosimilars […]